Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1999

Study Completion Date

May 31, 2003

Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

carboplatin

DRUG

epirubicin hydrochloride

DRUG

paclitaxel

PROCEDURE

conventional surgery

Trial Locations (18)

3049

Hospitais da Universidade de Coimbra (HUC), Coimbra

9100

Aalborg Hospital, Aalborg

20133

Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano (Milan)

21100

Ospedale di Circolo e Fondazione Macchi, Varese

25123

Spedali Civili, Brescia

55805

St. Mary's/Duluth Clinic Cancer Center, Duluth

91031

Shaare Zedek Medical Center, Jerusalem

B-3000

U.Z. Gasthuisberg, Leuven

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

R3E 0V9

CancerCare Manitoba, Winnipeg

L8V 5C2

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton

J1H 5N4

CHUS-Hopital Fleurimont, Fleurimont

G1R 2J6

Centre Hospitalier Universitaire de Quebec, Québec

DK-5000

Odense University Hospital, Odense

7500 KA

Medisch Spectrum Twente, Enschede

N-0310

Norwegian Radium Hospital, Oslo

1099-023 Codex

Instituto Portugues de Oncologia de Francisco Gentil - Centro de Lisboa, Lisbon

08.017

Institut d'Oncologia Corachan, Barcelona

Sponsors
All Listed Sponsors
collaborator

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

collaborator

NCIC Clinical Trials Group

NETWORK

lead

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

OTHER